Ricklie Julian, MD | Cancer Center

Dr. Ricklie A. Julian

Claim this profile

Banner University Medical Center - Tucson

Studies Squamous Cell Carcinoma
Studies Throat Cancer
8 reported clinical trials
16 drugs studied

Area of expertise

1Squamous Cell Carcinoma
Ricklie A. Julian has run 5 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
p16 negative
Stage III
Stage IV
2Throat Cancer
Ricklie A. Julian has run 3 trials for Throat Cancer. Some of their research focus areas include:
p16 positive
p16 negative
EGFR positive

Affiliated Hospitals

Image of trial facility.
Banner University Medical Center - Tucson
Image of trial facility.
University Of Arizona Cancer Center-North Campus

Clinical Trials Ricklie A. Julian is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Image of trial facility.

Immunotherapy + Radiotherapy

for Non-Small Cell Lung Cancer

This trial is testing a new treatment for advanced lung cancer using special immune cells from healthy donors and a small amount of radiation. The goal is to see if this combination is safe and effective. The immune cells help the body fight cancer, and the radiation makes the cancer cells easier to attack.
Recruiting1 award Phase 110 criteria

More about Ricklie A. Julian

Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ricklie A. Julian has experience with
  • Cisplatin
  • Atezolizumab
  • Intensity-Modulated Radiation Therapy
  • Cetuximab
  • Nivolumab
  • Abemaciclib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Ricklie A. Julian specialize in?
Is Ricklie A. Julian currently recruiting for clinical trials?
Are there any treatments that Ricklie A. Julian has studied deeply?
What is the best way to schedule an appointment with Ricklie A. Julian?
What is the office address of Ricklie A. Julian?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security